PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
First Trust Nasdaq Pharmaceuticals ETF (FTXH)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISINUS33738R8372
CUSIP33738R837
IssuerFirst Trust
Inception DateSep 20, 2016
RegionNorth America (U.S.)
CategoryHealth & Biotech Equities
Index TrackedNasdaq U.S. Smart Pharmaceuticals Index
Home Pagewww.ftportfolios.com
Asset ClassEquity

Asset Class Size

Multi-Cap

Asset Class Style

Blend

Expense Ratio

The First Trust Nasdaq Pharmaceuticals ETF has a high expense ratio of 0.60%, indicating higher-than-average management fees.


0.50%1.00%1.50%2.00%0.60%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with FTXH

First Trust Nasdaq Pharmaceuticals ETF

Popular comparisons: FTXH vs. FXAIX, FTXH vs. IAGG, FTXH vs. VOO, FTXH vs. BBP, FTXH vs. XLV, FTXH vs. PPH, FTXH vs. IHE, FTXH vs. SMH, FTXH vs. SPUS

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in First Trust Nasdaq Pharmaceuticals ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


20.00%40.00%60.00%80.00%100.00%120.00%140.00%OctoberNovemberDecember2024FebruaryMarch
50.04%
144.83%
FTXH (First Trust Nasdaq Pharmaceuticals ETF)
Benchmark (^GSPC)

S&P 500

Returns By Period

First Trust Nasdaq Pharmaceuticals ETF had a return of 5.49% year-to-date (YTD) and 10.42% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date5.49%10.16%
1 month-0.93%3.47%
6 months9.59%22.20%
1 year10.42%30.45%
5 years (annualized)6.79%13.16%
10 years (annualized)N/A10.89%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20241.33%2.82%
20231.26%-4.58%-5.97%3.91%7.05%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
FTXH
First Trust Nasdaq Pharmaceuticals ETF
0.88
^GSPC
S&P 500
2.79

Sharpe Ratio

The current First Trust Nasdaq Pharmaceuticals ETF Sharpe ratio is 0.88. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00OctoberNovemberDecember2024FebruaryMarch
0.88
2.79
FTXH (First Trust Nasdaq Pharmaceuticals ETF)
Benchmark (^GSPC)

Dividends

Dividend History

First Trust Nasdaq Pharmaceuticals ETF granted a 1.36% dividend yield in the last twelve months. The annual payout for that period amounted to $0.38 per share.


PeriodTTM20232022202120202019201820172016
Dividend$0.38$0.41$0.30$0.28$0.21$0.16$0.18$0.47$0.03

Dividend yield

1.36%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.16%

Monthly Dividends

The table displays the monthly dividend distributions for First Trust Nasdaq Pharmaceuticals ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024$0.00$0.00
2023$0.00$0.00$0.10$0.00$0.00$0.12$0.00$0.00$0.07$0.00$0.00$0.12
2022$0.00$0.00$0.05$0.00$0.00$0.04$0.00$0.00$0.09$0.00$0.00$0.13
2021$0.00$0.00$0.08$0.00$0.00$0.05$0.00$0.00$0.04$0.00$0.00$0.11
2020$0.00$0.00$0.06$0.00$0.00$0.05$0.00$0.00$0.04$0.00$0.00$0.06
2019$0.00$0.00$0.03$0.00$0.00$0.04$0.00$0.00$0.05$0.00$0.00$0.04
2018$0.00$0.00$0.08$0.00$0.00$0.04$0.00$0.00$0.03$0.00$0.00$0.04
2017$0.00$0.00$0.03$0.00$0.00$0.06$0.00$0.00$0.38$0.00$0.00$0.00
2016$0.03

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-0.93%
0
FTXH (First Trust Nasdaq Pharmaceuticals ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the First Trust Nasdaq Pharmaceuticals ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the First Trust Nasdaq Pharmaceuticals ETF was 32.11%, occurring on Mar 23, 2020. Recovery took 82 trading sessions.

The current First Trust Nasdaq Pharmaceuticals ETF drawdown is 0.93%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-32.11%Jan 17, 202045Mar 23, 202082Jul 20, 2020127
-23.42%Aug 29, 201876Dec 24, 2018254Jan 14, 2020330
-14.62%Jan 30, 201859May 3, 201853Aug 7, 2018112
-14.58%Dec 5, 2022226Oct 27, 202379Feb 22, 2024305
-14.29%Apr 11, 2022117Sep 27, 202245Nov 30, 2022162

Volatility

Volatility Chart

The current First Trust Nasdaq Pharmaceuticals ETF volatility is 3.16%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%OctoberNovemberDecember2024FebruaryMarch
3.16%
2.80%
FTXH (First Trust Nasdaq Pharmaceuticals ETF)
Benchmark (^GSPC)